Clinical trial
Tolerability Improvement of Tramadol/Acetaminophen (Ultracet) by Titration in Korean OA Patients:Multicenter, Randomized, Double-blind Study
NCT01063842 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability Improvement of Tramadol/Acetaminophen (Ultracet) by Titration in Korean OA Patients:Multicenter, Randomized, Double-blind Study
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- May 31, 2006
- Enrollment
- 250 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.